BioNTech CEO Ugur Sahin said Thursday that the COVID-19 vaccine developed with Pfizer should be roughly as effective against the new variant first detected in India, with it expected to be 70 to 75 per cent effective at protecting against infections.
- Two COVID-19 shots effective against U.K., India variants: study
- Saskatchewan health lifts waiting period for COVID-19-recovered individuals to receive vaccine
- BioNTech vaccine should be up to 75% effective against India COVID-19 variant: CEO